Eola Kukk
Publications by Year
Research Areas
Angiogenesis and VEGF in Cancer, Lymphatic System and Diseases, Vascular Tumors and Angiosarcomas, Lymphoma Diagnosis and Treatment, Hematopoietic Stem Cell Transplantation
Most-Cited Works
- → A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases.(1996)1,679 cited
- → Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4)(1998)1,203 cited
- → VEGF-C receptor binding and pattern of expression with VEGFR-3 suggests a role in lymphatic vascular development(1996)692 cited
- → Genomic Organization of Human and Mouse Genes for Vascular Endothelial Growth Factor C(1997)207 cited
- → Vascular Endothelial Growth Factor Receptor-3(1999)108 cited
- → Novel Human Vascular Endothelial Growth Factor Genes VEGF-B and VEGF-C Localize to Chromosomes 11q13 and 4q34, Respectively(1996)105 cited
- → The Tie receptor tyrosine kinase is expressed by human hematopoietic progenitor cells and by a subset of megakaryocytic cells(1996)81 cited
- → Analysis of Tie receptor tyrosine kinase in haemopoietic progenitor and leukaemia cells(1997)61 cited
- receptor 2 (Flk1) and VEGF receptor 3 (Flt4) Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF(2007)